Risk of Cardiovascular Disease Death in Older Malignant Melanoma Patients: A Population-Based Study
Noncancer deaths account for a large proportion of deaths in patients with malignant melanoma (MM), but the risk of cardiovascular disease (CVD) death in older MM patients remains unclear. This study aimed to estimate the risk of CVD death in older MM patients. Data on older MM patients were obtaine...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-09-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/14/19/4783 |
| _version_ | 1797480237743734784 |
|---|---|
| author | Jiapeng Miao Yujie Wang Xiaoyu Gu Wenrui Lin Zhen Ouyang Mi Wang Mingliang Chen Shuang Zhao Xianggui Wang Juan Su |
| author_facet | Jiapeng Miao Yujie Wang Xiaoyu Gu Wenrui Lin Zhen Ouyang Mi Wang Mingliang Chen Shuang Zhao Xianggui Wang Juan Su |
| author_sort | Jiapeng Miao |
| collection | DOAJ |
| description | Noncancer deaths account for a large proportion of deaths in patients with malignant melanoma (MM), but the risk of cardiovascular disease (CVD) death in older MM patients remains unclear. This study aimed to estimate the risk of CVD death in older MM patients. Data on older MM patients were obtained in the Surveillance, Epidemiology, and End Results database. Risk of CVD death was calculated by standardized mortality rates (SMRs), cumulative mortality and proportion of different causes of death. MM patients had a higher risk of CVD death than general populations (SMR = 1.98; 95% CI 1.93–2.03, <i>p</i> < 0.001). CVD death was more common in MM patients who were diagnosed at age 85 or older, had a localized stage, were white, had surgical treatment, had a primary head/neck/upper limb site and had a low-grade and superficial spreading/lentigo malignant pathologic type. Cumulative CVD mortality was more common than primary cancer in all older age groups, male or female, and patients with localized-stage disease. Other than primary cancer, CVD was the main cause of death in older patients diagnosed with MM. Our findings highlight CVD death is an important competing event of deaths in older MM patients, and more attention should be paid to reducing CVD death to improve survival. |
| first_indexed | 2024-03-09T21:57:13Z |
| format | Article |
| id | doaj.art-f2e72da811504b16beae7f26d7cd7343 |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-09T21:57:13Z |
| publishDate | 2022-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-f2e72da811504b16beae7f26d7cd73432023-11-23T19:56:32ZengMDPI AGCancers2072-66942022-09-011419478310.3390/cancers14194783Risk of Cardiovascular Disease Death in Older Malignant Melanoma Patients: A Population-Based StudyJiapeng Miao0Yujie Wang1Xiaoyu Gu2Wenrui Lin3Zhen Ouyang4Mi Wang5Mingliang Chen6Shuang Zhao7Xianggui Wang8Juan Su9Department of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Clinical Research Center for Cancer Immunotherapy, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, ChinaDepartment of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Clinical Research Center for Cancer Immunotherapy, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, ChinaDepartment of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Clinical Research Center for Cancer Immunotherapy, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, ChinaDepartment of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Clinical Research Center for Cancer Immunotherapy, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, ChinaDepartment of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Clinical Research Center for Cancer Immunotherapy, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, ChinaDepartment of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Clinical Research Center for Cancer Immunotherapy, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, ChinaDepartment of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Clinical Research Center for Cancer Immunotherapy, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, ChinaDepartment of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Clinical Research Center for Cancer Immunotherapy, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, ChinaDepartment of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Clinical Research Center for Cancer Immunotherapy, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, ChinaDepartment of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Clinical Research Center for Cancer Immunotherapy, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, ChinaNoncancer deaths account for a large proportion of deaths in patients with malignant melanoma (MM), but the risk of cardiovascular disease (CVD) death in older MM patients remains unclear. This study aimed to estimate the risk of CVD death in older MM patients. Data on older MM patients were obtained in the Surveillance, Epidemiology, and End Results database. Risk of CVD death was calculated by standardized mortality rates (SMRs), cumulative mortality and proportion of different causes of death. MM patients had a higher risk of CVD death than general populations (SMR = 1.98; 95% CI 1.93–2.03, <i>p</i> < 0.001). CVD death was more common in MM patients who were diagnosed at age 85 or older, had a localized stage, were white, had surgical treatment, had a primary head/neck/upper limb site and had a low-grade and superficial spreading/lentigo malignant pathologic type. Cumulative CVD mortality was more common than primary cancer in all older age groups, male or female, and patients with localized-stage disease. Other than primary cancer, CVD was the main cause of death in older patients diagnosed with MM. Our findings highlight CVD death is an important competing event of deaths in older MM patients, and more attention should be paid to reducing CVD death to improve survival.https://www.mdpi.com/2072-6694/14/19/4783malignant melanomacardio-oncologycardiovascular disease death |
| spellingShingle | Jiapeng Miao Yujie Wang Xiaoyu Gu Wenrui Lin Zhen Ouyang Mi Wang Mingliang Chen Shuang Zhao Xianggui Wang Juan Su Risk of Cardiovascular Disease Death in Older Malignant Melanoma Patients: A Population-Based Study Cancers malignant melanoma cardio-oncology cardiovascular disease death |
| title | Risk of Cardiovascular Disease Death in Older Malignant Melanoma Patients: A Population-Based Study |
| title_full | Risk of Cardiovascular Disease Death in Older Malignant Melanoma Patients: A Population-Based Study |
| title_fullStr | Risk of Cardiovascular Disease Death in Older Malignant Melanoma Patients: A Population-Based Study |
| title_full_unstemmed | Risk of Cardiovascular Disease Death in Older Malignant Melanoma Patients: A Population-Based Study |
| title_short | Risk of Cardiovascular Disease Death in Older Malignant Melanoma Patients: A Population-Based Study |
| title_sort | risk of cardiovascular disease death in older malignant melanoma patients a population based study |
| topic | malignant melanoma cardio-oncology cardiovascular disease death |
| url | https://www.mdpi.com/2072-6694/14/19/4783 |
| work_keys_str_mv | AT jiapengmiao riskofcardiovasculardiseasedeathinoldermalignantmelanomapatientsapopulationbasedstudy AT yujiewang riskofcardiovasculardiseasedeathinoldermalignantmelanomapatientsapopulationbasedstudy AT xiaoyugu riskofcardiovasculardiseasedeathinoldermalignantmelanomapatientsapopulationbasedstudy AT wenruilin riskofcardiovasculardiseasedeathinoldermalignantmelanomapatientsapopulationbasedstudy AT zhenouyang riskofcardiovasculardiseasedeathinoldermalignantmelanomapatientsapopulationbasedstudy AT miwang riskofcardiovasculardiseasedeathinoldermalignantmelanomapatientsapopulationbasedstudy AT mingliangchen riskofcardiovasculardiseasedeathinoldermalignantmelanomapatientsapopulationbasedstudy AT shuangzhao riskofcardiovasculardiseasedeathinoldermalignantmelanomapatientsapopulationbasedstudy AT xiangguiwang riskofcardiovasculardiseasedeathinoldermalignantmelanomapatientsapopulationbasedstudy AT juansu riskofcardiovasculardiseasedeathinoldermalignantmelanomapatientsapopulationbasedstudy |